Disclosed is as a substituted thiazolamine derivative represented by Formula I or a pharmaceutically acceptable salt thereof or a hydrate thereof (the definitions of each group in the formula are as presented in the description), and the application thereof in the prevention and/or treatment of viral diseases induced by picornavirus. Also disclosed is a pharmaceutical composition containing the compound.
本发明涉及一种由式I表示的取代
噻唑胺衍
生物,或其药学上可接受的盐或
水合物(式中每个基团的定义如说明书所述),以及其在预防和/或治疗由小肠病毒引起的病毒性疾病中的应用。同时还公开了一种含有该化合物的药物组合物。